NCT02270814: Cisplatin, Nab-Paclitaxel, and Cetuximab (CACTUX) in Patients With Incurable Head and Neck Squamous Cell Carcinoma
- State
- Under way
- Phase
- Phase 2
- People
- 74 taking part
- Started
- 2 Feb 2015
- Primary completion
- 30 Sep 2026
- Arms
- CACTUX: nab-paclitaxel, cisplatin (or carboplatin), cetuximab
- Results
- None posted
- 21 Oct 2014: Trial registered
- 2 Feb 2015: Trial started